India: Nestle and Dr Reddy’s announce joint venture for nutraceutical brands

The Indian arm of consumer goods giant Nestle and Indian multinational pharmaceutical company Dr Reddy’s have formed a joint venture to offer new nutraceutical brands to consumers in India and other agreed territories.

The joint venture will establish its headquarters in Hyderabad, and select brands will be licenced by both parties. Nestle Group will license brands such us Nature’s Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal & Resource Dialysis, while Dr. Reddy’s will licence Rebalanz, Celevida, Antoxid, Kidrich-D3 and Becozinc in the nutrition, and OTC segments.

Commenting on the move, Nestle India chairman and managing director Suresh Narayanan commented: “This joint venture [will allow] us to bring our science-backed nutritional solutions to more people across the country. Dr. Reddy’s is a trusted name in the pharmaceutical space and shares our commitment to provide access to high quality products. This joint venture will enable us to build a robust retail and distribution network to take our brands closer to consumers and making a meaningful difference to improve the quality of life”.

The company is expected to start operations in the second quarter of 2025.

Source: Nestle / Dr Reddy’s